Stryker Corp

General ticker "SYK" information:

  • Sector: Health Care
  • Industry: Health Care Equipment & Supplies
  • Capitalization: $136.3B (TTM average)

Stryker Corp follows the US Stock Market performance with the rate: 71.3%.

Estimated limits based on current volatility of 3.8%: low 332.23$, high 358.70$

Factors to consider:

  • Company included in S&P500 list
  • Company pays dividends (quarterly): last record date 2025-03-31, amount 0.84$ (Y0.96%)
  • US accounted for 75.0% of revenue in the fiscal year ended 2024-12-31
  • Price in estimated range

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2024-12-31 to 2026-12-31

  • 2024-12-31 to 2025-12-31 estimated range: [331.88$, 428.50$]
  • 2025-12-31 to 2026-12-31 estimated range: [322.83$, 422.69$]

Financial Metrics affecting the SYK estimates:

  • Positive: Non-GAAP EPS, $ of 12.19 > 2.18
  • Positive: 8.42 < Operating profit margin, % of 16.33
  • Negative: Industry operating cash flow per share per price (median), % of -3.89 <= 2.91
  • Negative: negative Industry operating income (median)
  • Positive: 1.81 < Operating cash flow per share per price, % of 2.95

Similar symbols

Short-term SYK quotes

2025-02-282025-03-032025-03-042025-03-052025-03-062025-03-072025-03-102025-03-112025-03-122025-03-132025-03-142025-03-172025-03-182025-03-192025-03-202025-03-212025-03-242025-03-252025-03-262025-03-272025-03-282025-03-312025-04-012025-04-022025-04-032025-04-042025-04-072025-04-082025-04-092025-04-10330340350360370380390400
Price $

Long-term SYK plot with estimates

250300350400Jul 2023Jan 2024Jul 2024Jan 2025Jul 2025Jan 2026Jul 2026Jan 202701234
SYKS&P500Health CareNon-GAAP EPS EstimateNon-GAAP EPS ActualPrice $Non-GAAP EPS $

Financial data

YTD 2022-12-31 2023-12-31 2024-12-31
Operating Revenue $18,449.00MM $20,498.00MM $22,595.00MM
Operating Expenses $15,608.00MM $16,610.00MM $18,906.00MM
Operating Income $2,841.00MM $3,888.00MM $3,689.00MM
Non-Operating Income $-158.00MM $-215.00MM $-197.00MM
R&D Expense $1,454.00MM $1,388.00MM $1,466.00MM
Income(Loss) $2,683.00MM $3,673.00MM $3,492.00MM
Taxes $325.00MM $508.00MM $499.00MM
Profit(Loss)* $2,358.00MM $3,165.00MM $2,993.00MM
Stockholders Equity $16,616.00MM $18,593.00MM $20,634.00MM
Inventory $3,995.00MM $4,843.00MM $4,774.00MM
Assets $36,884.00MM $39,912.00MM $42,971.00MM
Operating Cash Flow $2,624.00MM $3,711.00MM $4,242.00MM
Capital expenditure $588.00MM $575.00MM $755.00MM
Investing Cash Flow $-2,924.00MM $-962.00MM $-3,000.00MM
Financing Cash Flow $-749.00MM $-1,594.00MM $-525.00MM
Earnings Per Share** $6.23 $8.34 $7.86

* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.